22 related articles for article (PubMed ID: 8409715)
1. Pharmacokinetics of Intraperitoneal Vancomycin and Amikacin in Automated Peritoneal Dialysis Patients With Peritonitis.
Falbo Dos Reis P; Barretti P; Marinho L; Balbi AL; Awdishu L; Ponce D
Front Pharmacol; 2021; 12():658014. PubMed ID: 34122079
[No Abstract] [Full Text] [Related]
2. ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment.
Li PK; Szeto CC; Piraino B; de Arteaga J; Fan S; Figueiredo AE; Fish DN; Goffin E; Kim YL; Salzer W; Struijk DG; Teitelbaum I; Johnson DW
Perit Dial Int; 2016 Sep; 36(5):481-508. PubMed ID: 27282851
[No Abstract] [Full Text] [Related]
3. The role of monitoring gentamicin levels in patients with gram-negative peritoneal dialysis-associated peritonitis.
Tang W; Cho Y; Hawley CM; Badve SV; Johnson DW
Perit Dial Int; 2014; 34(2):219-26. PubMed ID: 24385334
[TBL] [Abstract][Full Text] [Related]
4. Experimental, clinical and preventive aspects of ototoxicity.
Chiodo AA; Alberti PW
Eur Arch Otorhinolaryngol; 1994; 251(7):375-92. PubMed ID: 7857625
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of intraperitoneal cefazolin and gentamicin in empiric therapy of peritonitis in continuous ambulatory peritoneal dialysis patients.
Tosukhowong T; Eiam-Ong S; Thamutok K; Wittayalertpanya S; Na Ayudhya DP
Perit Dial Int; 2001; 21(6):587-94. PubMed ID: 11783768
[TBL] [Abstract][Full Text] [Related]
6. Vestibular toxicity due to gentamicin in peritoneal dialysis patients.
Chong TK; Piraino B; Bernardini J
Perit Dial Int; 1991; 11(2):152-5. PubMed ID: 1854873
[TBL] [Abstract][Full Text] [Related]
7. Vancomycin administration in continuous ambulatory peritoneal dialysis: the risk of ototoxicity.
Gendeh BS; Gibb AG; Aziz NS; Kong N; Zahir ZM
Otolaryngol Head Neck Surg; 1998 Apr; 118(4):551-8. PubMed ID: 9560111
[TBL] [Abstract][Full Text] [Related]
8. Gentamicin administration via peritoneal dialysis fluid: the risk of ototoxicity.
Gendeh BS; Said H; Gibb AG; Aziz NS; Zahir ZM
J Laryngol Otol; 1991 Dec; 105(12):999-1001. PubMed ID: 1787382
[TBL] [Abstract][Full Text] [Related]
9. Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.
Mars RL; Moles K; Pope K; Hargrove P
Adv Perit Dial; 2000; 16():280-4. PubMed ID: 11045311
[TBL] [Abstract][Full Text] [Related]
10. Gentamicin ototoxicity in continuous ambulatory peritoneal dialysis.
Gendeh BS; Said H; Gibb AG; Aziz NS; Kong N; Zahir ZM
J Laryngol Otol; 1993 Aug; 107(8):681-5. PubMed ID: 8409715
[TBL] [Abstract][Full Text] [Related]
11. [Continuous ambulatory peritoneal dialysis].
Faller B
Rev Prat; 1991 Apr; 41(12):1080-4. PubMed ID: 2052868
[TBL] [Abstract][Full Text] [Related]
12. [Peritoneal dialysis-related eosinophilic peritonitis: a case report and literature review].
Tsai SM; Yan Y; Zhao HP; Wu B; Zuo L; Wang M
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Aug; 50(4):747-751. PubMed ID: 30122784
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
